Journal of Clinical Images and Medical Case Reports

ISSN 2766-7820
Case Report - Open Access, Volume 2

Quality of life assessment in patients with a stoma due to rectal cancer in Morocco

Yacir El Alami1,2*; Hadj Omar El Malki3; Said Benamr4

1 Surgical Department, National Institute of Oncology, Rabat, Morocco

2 Doctoral Studies Center for Health and Life Sciences (CEDOC SVS) Faculty of Medicine and Pharmacy, Mohammed V University – Rabat, Morocco.

3 Mohammed V University, Medical School, Surgery Department ‘A’, Ibn Sina, Hospital, Rabat, Morocco.

4 Mohammed V University, Medical School, Surgery Department ‘B’, Ibn Sina, Hospital, Rabat, Morocco.

*Corresponding Author: Yacir El Alami
Clinique Chirurgicale B. CHU Ibn Sina - Rabat, Morocco.
Email: [email protected]

Received : Oct 25, 2021

Accepted : Dec 09, 2021

Published : Dec 16, 2021

Archived : www.jcimcr.org

Copyright : © El Alami Y (2021).

Abstract

Colorectal cancer is a major public health problem in Morocco, according to the Moroccan.

Cancer Registry; it represents the first gastro-intestinal cancer and the third most common cancer in Morocco. The aim of this paper is to compare the quality of life of rectal cancer patients with and without permanent colostomy in the course of rectal cancer treatment.

Methods: Patients were recruited from the National Institute of Oncology in Rabat – Morocco, during the February 2016 - June 2018 period. The version of the third QLQ-C30 and C29 questionnaire of the European Organization for Research and Treatment of Cancer (EORTC) was translated for the first time in Moroccan Arabic and used to obtained relevant data.

Psychometric properties were measured on patients with colorectal cancer recruited from different regions of the country. Statistical analysis included Cronbach’s alpha, correlation, multi-trait scaling and known groups comparisons. p value ≤ 0.05 was considered significant.

Results: In total, 102 patients with rectal cancer were included in the study and 45 (44 %) patients with stoma. The mean age at diagnosis time was 51 years (+/- 11.4). Stoma patients did not show significant impairment of functioning, which did not negatively influence their quality of life.

Patients with stoma had higher symptom scores related to diarrhea and experienced more financial difficulty as measured by EORTC C-30, in clinically distinct group comparison. With EORTC C-29, this group showed lower Functional scales scores for body image, sexual dysfunction for female patients and higher symptom scores related to urinary frequency, troubles with taste, hair loss, sore skin, psychosocial disturbance in the form of embarrassment due to the frequent need to change the stoma bag compared to patients without a stoma.

Conclusions: The experience of stoma has a not large negative impact on Moroccan patients’ quality of life. Influence of stoma is most pronounced in the area of symptom and financial difficulty. Financial difficulties are, by far, more present.

Keywords: quality of life; intestinal stoma; colo-rectal cancer.

Abbreviations: EORTC: European Organization for Research and Treatment of Cancer; QLQ: Quality of Life Questionnaire.

Citation: Alami Y, Malki H, Benamr S. Quality of life assessment in patients with a stoma due to rectal cancer in Morocco. J Clin Images Med Case Rep. 2021; 2(6): 1483.

Background

The colorectal cancer is a major public health problem in Morocco, according to the Moroccan.

Cancer Registry, it represents the first gastro-intestinal cancer and the third most common cancer in Morocco, as it represents 6.7 % of all cancers in Morocco, as per the standardized rates on the world population, and the Moroccan population was respectively 9.6 and 7.8 for 100,000 inhabitants in 2012. These rates were slightly higher among men compared to women [1]. The European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire core (QLQ-C30 and QLQ-C29) are frequently used in cancer of the colorectal [2- 4]. The questionnaire has been validated across many cultures and disease conditions and was found to have adequate acceptable psychometric properties.

In order to develop an integrated modality for assessing the QLQ in patients with colorectal cancer, the EORTC working group on QLQ subsequently developed the QLQ- CR29 [5].

In addition to being more sensitive to novel therapies, the new shorter QLQ- CR29 enables sexual functioning to be assessed over a 4- week period and to be analyzed independently of the other domains [6]. To address the limitations of the EORTC QLQ- CR30, the EORTC QLQ- CR29 is now the specific supplementary module for to be used in a combination with EORTC QLQ- CR30 and should be adapted, and translated into the Moroccan Arabic language in the near future in the Moroccan colorectal cancer population.

The EORTC QLQ-C30 questionnaire was previously translated into the Moroccan Arabic Dialectal version [7]. However, the psychometric properties of QLQ-C30 and C-29 in colorectal cancer have never been examined, especially in Patients with a stoma despite the fact that this cancer represents an important public health burden and there is an increasing need to assess quality of life experienced by patients with this cancer and to release appropriate treatment in Morocco.

The objective of this study was to compare the quality of life in rectal cancer patients with or without permanent colostomy in colorectal cancer patients receiving treatment at the National Institute of oncology in Rabat.

Materials and methods

Patient’s recruitment

Colorectal cancer patients were recruited from the National Institute of Oncology in Rabat –Morocco during the February 2015 - June 2017 period. These patients were from different regions of the country, as the National Institute of Oncology of Rabat is the main cancer treatment centre in the country. Adult patients (≥18 years) with histologically proven colorectal cancer were eligible to enter the study. Demographic and clinical data were retrieved from the patients’ medical records. A written informed consent was required for recruitment in the study. All the patient has received the information’s regarding the conditions of the study. This study received Ethical approval from the ethics committees of the Mohamed V Faculty of Medicine and Pharmacy and the National Institute of Oncology in Rabat, Morocco.

Instruments and procedures

The Moroccan Arabic version of the EORTC QLQ-C30 and QLQ-C29 was used to obtain relevant data. Participants were requested to complete the questionnaire by themselves or with the help of an interviewer while waiting to see the doctor at the outpatient surgical clinic or immediately after their consultation. Reference values from the literature were used to compare the obtained results [8].

Statistical analysis

Descriptive statistics were performed using mean or median and standard deviations. The internal-consistency reliability of the multi-item scales was assessed by Cronbach’s a coefficient. A value of 0.70 or greater was considered adequate. Clinically distinct group’s validity was examined by comparing the scores of patients with and without stoma as well as localization of cancer in the colon and rectum using Mann Whitney u-test. All statistical analyses were performed using SPSS version 18.

Results

Patient’s characteristics

In total, 102 patients with colorectal cancer were included in the study, of which there were 40 patients (39%) with colon cancer, 62 patients (61%) with rectal cancer. Among them 45 patients (44%) had a stoma. The mean patient age at diagnosis was 51 years (+/- 11.4) (range: 28–76). The male – female sex ratio was 1.48. 71 patients (70%) married were and came from urban areas. (56%) without formal education and had a low-intermediate socio-economic status, and 71 (70%) had no medical insurance.

Acceptability of questionnaires and preferences

The average time required to complete the questionnaire was from 9.6 to 17 min and more than 67 patients (56%) could not respond the questionnaire without the help of an interviewer. Patients considered the time of administration, which was immediately after the medical consultation, to be inappropriate.

Internal consistency

The internal consistencies of the Moroccan Arabic version of versions of the EORTC QLQ-C30 were acceptable with Cronbach’s alpha (α≥0.70) in the global health status/overall quality of life (GHS/ QOL)(P=0.678), and all of the functioning and multi-item symptom scales.

In all assessed domains, stoma patients did not show significant impairment of functioning, which did not negatively influence their quality of life. All results are shown in Table 1. Mean score of physical functioning, social roles and emotional scale did not show a difference of points compared to the reference. The presence of a stoma also did not significantly influence functions scales with EORTC C-29 group.

Table 1:Demographic and clinical features of patients (n=102).

Variable

No

Percentage (%)

Age

 

 

    Mean  (SD)

 

51 (11.4)

    Range

 

28-76

Gender

 

 

     Male

61

60.0

     Female

41

40.0

Marital status

 

 

    Single

18

17.6

    Married

71

69.6

    Other

13

12.7

Educational status

 

 

    Illiterate

53

52.0

    Primary school and college

37

36.3

    High school

12

11.8

Living environment

 

 

   Urban

71

69.6

   Rural

31

30.5

Socioeconomic status

 

 

    Low

57

55.8

    Intermediate

39

38.2

    high

6

5.9

localization

 

 

   Colon

40

39.2

   Rectum

62

60.7

Stoma

 

 

    Yes

45

44.1

    No

57

55.8

Medical insurance

 

 

    Yes

31

30.4

    No

71

69.6


Table 2:Internal consistencyEORTC QLQ-C30 scores.

scale

 

Cronbach’s alpha

 

 

 

overall

With stoma

Without stoma

Global health status / quality of life

 

 

 

Global health status / quality of life

0.82

0.87

0.81

Functioning scales

 

 

 

Physical

0.79

0.83

0.79

Role

0.82

0.88

0.81

Emotional

0.80

0.84

0.80

Cognitive

0.80

0.85

0.79

Social and Family

0.83

0.83

0.83

Multi-item symptoms scales

 

 

 

Fatigue

0.78

0.83

0.76

Nausea/Vomiting 

0.83

0.86

0.82

Pain 

0.79

0.83

0.79


Table 3:EORTC QLQ-C30 scores (functional scales).

General quality of life

 

Cronbach’s alpha

 

 

With stoma

Reference value

Difference

Functioning scales

 

 

 

Physical

0.83

0.90

0.07

Role

0.88

0.88

0.00

Emotional

0.84

0.78

-0.06

Cognitive

0.85

0.91

0.06

Social and Family

0.83

0.91

0.08

On the other hand, patients with stoma who took the EORTC QLQ-C29 version reported lower functional scores for body image (P=0,004), sexual dysfunction for female (P =0,036) patients and higher symptom scores related to urinary frequency (P=0,045), troubles with taste (P =0,033), hair loss (P =0,001), sore skin (P =0,027), psychosocial disturbance in the form of embarrassment (P =0,032) due to the frequent need to change the stoma bag compared to patients without a stoma (Table 5).

Clinically distinct group comparison

Patients in version of the EORTC QLQ-C30with stoma had a higher symptom scores related to diarrhea (p=0.013) and more financial difficulty (P =0.035) as compared with patients without stoma (Table 4).

Table 4:EORTC QLQ-C29 scores (functional scales).

QLQ-CR29 Scales

Without a stoma  n=61

With a stoma n=41

 

Convergent

Divergent

α

Convergent

Divergent

α

Urinary frequency

0.93-0.94

0.03-0.31

0,70

0.88-0.90

0.10-0.53

0,65

Blood and mucus in stools

0.80-0.84

0.14-0.58

0,61

0.83-0.89

0.26-0.54

0,63

Stool frequency

0.92-0.93

0.11-0.50

0,69

0.90-0.97

0.03-0.51

0,62

Body image

0.76-0.84

0.01-0.21

0,77

0.70-0.84

0.01-0.46

0,80


Table 5:Group comparison version QLQ-C30 between patients with and without a stoma.

 

Stoma= 45

No Stoma=57

P- value

 

Mean / Median   (SD)

Mean / Median   (SD)

 

GHS/ QOL

66.7      19.8

63.4     21.9

0.678

Physical function 

66.1       21.3

70.2     19.5

0.131

Role function

55.5       30.4

60.4      31.4

0.148

Emotional function

65.2       30.7

66.1     25.7

0.907

Cognitive function

83.3        26.5

83.9      23.7

0.419

Social function

79.1         27.6

86.6     25.6

0.151

fatigue

51.8         29.3

44.6     27.3

0.734

Nausea /vomiting

13.8        21.1

9.4      18.3

0.593

Pain

36.1        32.4

40.8      33.3

0.839

Dyspnoea

30.5        41.3

20.2      29.1

0.882

Insomnia

47.2        41.3

40.5      39.6

0.588

Appetite loss

36.1        36.1

26.1      32.8

0.221

Constipation

39.1        37.2

28.6      33.6

0.154

Diarrhoea

32.9        36.3

14.9      21.1

0.013

Financial difficulty

65.1        39.8

54 .7     38.7

0.035


Table 6:Group comparison version QLQ-C29 between patients with and without a stoma.

 

With a stoma =45

Without a stoma

P- value

 

Mean/ (SD)

Mean(SD)

 

Functional scales

 

 

 

Body image

61.3   27.6

77.7    25.8

0,004

Anxiety

63.2   34.8

69.2    32.6

0,398

Weight

67.8    35.0

74.7    30.3

0,306

Sexual function (men)

53.3    39.4

40.1    39.0

0,252

Sexual function (women)

52.3    38.5

73.1    35.4

0,036

Symptom scales

 

 

 

Urinary frequency

32.1    28.4

46.7   34.9

0,045

Blood and mucus in stool

28.1    31.5

35.5    30.4

0,263

Stool frequency

21.8     31.2

20.5    30.9

0,841

Urinary incontinence

22.9    32.2

26.3     35.3

0,647

Dysuria

34.4     33.9

36.6    35.5

0,775

Abdominal pain

35.635.5

40.238.6

0,566

Buttock pain

33.334.5

37.735.2

0,558

Bloated feeling

29.8     37.1

29.6     37.0

0,978

Dry mouth

11.4     22.3

12.8     27.1

0,812

Hair loss

32.1     37.2

16.8     31.9

0,033

Trouble with taste

65.5      36.1

36.2     38.3

0,001

Flatulence

31.0     35.5

23.0      34.6

0,287

Fecal incontinence

36.7     28.6

33.6     37.3

0,684

Sore skin

36.7     37.1

23.8     38.2

0,027

Embarrassment

71.7      27.7

40.         0

0,032

Stoma care problems

46.6   37.3

32.0   36.3

0,177

Discussion

The aim of this study was to compare quality of life using the EORTC questionnaire: QLQ-C30 and QLQ-CR29 in colorectal cancer patients with or without permanent colostomy receiving treatment at the National Institute of Oncology in Morocco.

The ability of the EORTC QLQ-C30 and QLQ-CR29 to differentiate between the global health status/overall quality of life (GHS/ QOL), symptom, financial difficulty and clinically distinct patient’s groups was examined based on the presence or absence of stoma.

The global health status was good and stoma patients did not show significant differences, which did not negatively influence their quality of life. The presence of a stoma also did not significantly influence cognitive and physical functioning, social roles and emotional group comparison version QLQ-C 30. However, in the group comparison with the QLQ-C29 version, the stoma patients showed significant difference in body image and sexual function women, which negatively influenced their quality of life.

Several authors have reported results comparable to those we havereported, namely the lack of difference in quality of life after treatment between the two groups of patients [9,10,11]. Other authors havereported better quality of life scores for the group of patients without stoma and this with a statistically significant difference [4,12,13]. Only one study reported better quality of life scores in the group patients with a permanent stoma. This is a study carried out in Norway and published in 2004 including patients in remission after treatment for rectal cancer in which authors unexpectedly discovered less anxiety, better self-esteem and a better ability to maintain social relationships in the group of patients with permanent stoma [14].

Several studies show that the quality of life of colorectal cancer patients treated with stoma is mostly reduced in the initial post-operative period [15]. The patients have high expectations with respect to surgical treatment, and formation of the stoma may be disappointing to them, but with time the quality of life scores improves. This may explain why stoma patients did not show significant impairment of functioning, which did not negatively influence their quality of life also by the “responsibility change”, or reformulation.

Patients suffering from potentially fatal colorectal cancer, realize with time the value of their saved lives, which allows them to have a more positive perception of their daily activities. This in turn leads to better scores in quality of life assessments [16- 18]. As a consequence, the assessment of quality of life in stoma patients is not unambiguous, and depends significantly on the time which has passed since the surgical treatment.

On the other hand, this study’s allowed to differentiate between patients with and without stoma, by showing higher symptom scores related to diarrhea (p=0.013) and financial difficulty (P =0.035) for patients with stoma. This is consistent with the chinese-malaysian study (Magaji et al. 2016) [19], finding high symptom scores on the financial difficulty scale as well as more impairment in their physical and social/family functioning and less constipation. In fact, the impairment of quality of life for patients with stoma compared to those without has been challenged in many studies that have proved either no difference or even a better quality of life. (Pachler and WilleJørgensen 2004). A recent Cochrane review involving thirty-five observational studies representing 5127 patients concluded that even though differences were observed between patients with and without a stoma, such differences were not consistent (Pachler and Wille- Jorgensen, 2012) [20].

In distinct group comparison, patients with a stoma bag presented more financial difficulty. This is because of the lower socioeconomic status of the patients and the shortcomings of the health financing system in Morocco, which does not subsidize all steps of cancer treatment. It is worth noting that the expensive price of stoma bags, transportation costs for care and hospital housing represent heavy financial burdens for patients. The number of studies in Morocco considering cancer-related financial difficulties is limited. More studies are needed to determine whether the publicly funded Moroccan healthcare system is able to protect colorectal cancer patients from financial havoc) [21].

Many studies reported that permanent stoma could significantly alter patients ‘quality of life by affecting negatively physical, sexual, social, and psychological aspects of life, especially in Islamic societies like Morocco where religious rituals are considered as an important factor of Social adaptation and improved quality of life. Indeed, daily praying and fasting were altered, since significantly greater number of Muslim who underwent APR stopped daily praying and did not fast during Ramadan [22,23]. In Islamic societies, religious rituals are considered as an important factor of social adaptation and improved quality of life. Kuzu et al. showed that social, physical, sexual, and psychological aspects of life, in addition to religious worship, are severely impaired by sphincter sacrificing surgery in the Islamic population [22].

Distinct group comparison shows a significant difference for the sexual function scale, with female patients with stoma reporting lower sexual function scores. This is due to female patients experiencing rejection or fear of rejection by their sexual partners. This is consistent with the study in which 80% of patients reported that the reason for their inactive sexual life was their spouse’s abdominal colostomy, which they found repulsive [23,24]. However, it must be noted that measurement of the sexual function scale was imperfect, as many patients refused to respond to this part of the questionnaire due to the cultural stigma and shame attached to sexuality in Moroccan society. Furthermore, this difference should be nuanced in light of the fact that most Moroccan men and women become sexually active only after marriage.

There are some limitations to our study. Due to the crosssectional nature of the study, we could not estimate the longterm effects of stoma on the quality of life of patients with colorectal patients.

Sexual functions and symptoms are the most difficult scales from which to draw conclusions, as many patients are reluctant to complete the questions or give the truth to doctors. Some studies were unable to evaluate sexual functions due to too many missing values [25].

Another possible limitation for this study is the small sample size of cancer patients in each disease subgroup and cancer location (rectum and colon) making it difficult to perform subgroup analyses. In addition, the majority of patients recruited came from outpatient rather than inpatient units, limiting further statistical analysis especially in assessing responsiveness over time.

Finally, the illiteracy of many participants limited the response rate to the questionnaire.

Conclusion

To our knowledge, this is the first study focused on the QLQ of patients with colorectal cancer patients using the QLQ-CR30 and QLQ-CR29 in Morocco. Our study was able to provide additional information about patient quality of life in colorectal cancer patients with or without permanent colostomy in Morocco. The creation of a stoma does not negatively impact the global health status of Moroccan colorectal cancer patients.

Declarations

Acknowledgments: To National Institute of Oncology, Rabat, Morocco and The Doctoral Studies Centre for Health and Life Sciences (CEDOC SVS), Clinical Research and Epidemiological Laboratory Faculty of Medicine and Pharmacy of Rabat. Mohammed V University – Rabat - Morocco for their support.

Availability of data and materials: All questionnaires and consents forms are available at National Institute of oncology in Rabat– Morocco where the study was conducted.

The data were pooled and analysed at the Clinical Research and Epidemiological Laboratory; Mohammed V University in Rabat, Morocco, Medical School.

Authors’ contributions: Y ELA has contributed to conception and design, acquisition of data, analysis and interpretation of data, wrote the manuscript; SB has contributed to conception and design, analysis and interpretation of data, has been involved in revising critically the manuscript for important intellectual content and has given final approval of the version to be published; HOE has contributed to conception and design, analysis and interpretation of data, has been involved in revising critically the manuscript for important intellectual content and has given final approval of the version to be published; All authors read and approved the final manuscript.

Competing interests: The authors declare that they have no competing interests.

Ethics approval and consent to participate: This study N° 79/2017 has been approved by the ethics committee of the Faculty of the medicine and pharmacy - University Mohamed V Rabat – Morocco and the ethics committees in the University Hospital Center Hassan II in Fez- Morocco (Nejjari et al. BMC Research Notes 2014, 7: 228 and all) the subjects were informed of the conditions related to the study and gave their written, informed consent.

References

  1. Cancer Registry of Grand Casablanca region Morocco: 2008- 2012. Edition 2016.
  2. El Alami Y, Essangri H, Majbar MA, Boutayeb S, Benamr S, et al. Psychometric validation of the Moroccan version of the EORTC QLQ-C30 in colorectal Cancer patients: cross-sectional study and systematic literature review. BMC Cancer. 2021; 21: 99.
  3. Ciorogar G, Zaharie F, Ciorogar A, Birta D, Degan A, et al. Quality of life outcomes in patients living with stoma. HVM Bioflux. 2016; 8:137-140.
  4. Abu Helalah MA. Alshraideh HA. Al Hanaqta MM. et al Quality of life and psychological well being of colorectal cancer survivors in Jordan. Asian Pac J Cancer Prev. 2014; 15: 7653-7664.
  5. Gujral S, Conroy T, Fleissner C, Sezer O, King PM, Avery KN, et al. European Organisation for Research and Treatment of Cancer Quality of Life Group. Assessing quality of life in patients with colorectal cancer: an update of the EORTC quality of life questionnaire. Eur J Cancer. 2007; 43: 1564-1573.
  6. Ganesh V, Agarwal A, Popovic M, Cella D, Mc Donald R, et al. Comparison of the FACT- C, EORTC QLQ- CR38, and QLQ- CR29 quality of life questionnaires for patients with colorectal cancer: A literature review. Support Care Cancer. 2016; 24: 3661-3668.
  7. Nejjari C, El Fakir S, Bendahhou K, El Rhazi K, Abda N, et al. Translation and validation of European organization for research and treatment of cancer quality of life questionnaire -C30 into Moroccan version for cancer patients in Morocco. BMC Res Notes. 2014; 7: 228.
  8. Kopp I, Bauhofer A, Koller M. Understanding quality of life in patients with colorectal cancer: Comparison of data from randomised controlledtrial, a population based cohort study and the norm reference population. Inflamm Res. 2004; 53 Suppl 2: S130–S135.
  9. Sideris L, Zenasni F, Vernerey D, Dauchy S, Lasser P, Pignon JP et al. Quality of life of patients operated on for low rectal cancer: Impact of the type of surgery and patients’ characteristics. Dis Colon Rectum. 2005; 48: 2180-2191
  10. Grumann MM, Noack EM, Hoffmann IA, Schlag PM. Comparaison of quality of life in patients undergoing abdominoperineal extirpation or anterior resection for rectal cancer. Ann Surg. 2001; 233: 149-156.
  11. Camilleri-Brennan J, Steele RJC. Objective assessment of morbidity and quality of life after surgery for low rectal cancer. Colorectal Disease. 2002; 4: 61-66.
  12. Li X, Song X, Chen Z, Li M, Lu L, Xu Y et al. Quality of life in rectal cancer patients after radical surgery : A survey of chinese patients. W J Surg Oncol. 2014; 12: 161-171.
  13. Engel J, Kerr J, Schlesinger Raab A, Eckel R, Sauer H, et al. Quality of life in rectal cancer patients. Ann Surg. 2003; 238: 203-213.
  14. Rauch P, Miny J, Conroy T, Neyton L, Guillemin F. Quality of life among disease-free survivors of rectal cancer. Journal of clinical oncology. 2004; 22.
  15. Braun DP, Gupta D, Grutsch JF, Staren ED. Can changes in health related quality of life scores predict survival in stages III and IV colorectal cancer? Health Qual Life Outcomes. 2011; 9: 62.
  16. Zajac O, Spychala A, Murawa D, Wasiewisc J, Foltyn P, et al. Quality of life assessment in patients with a stoma due to rectal cancer . Rep Pract Oncol Radiother. 2008; 13/3/: 130–134.
  17. Wilson TR, Alexander DJ, Kind P iwsp. Measurement of health related quality of life in the early follow-up of colon and rectal cancer. Dis Colon Rectum. 2006; 49: 1692–1702.
  18. Arndt V, Merx H, Stegmaieriwsp. Restrictions in quality of life in colorectal cancer patients over three years after diagnosis: A population based study. Eur J Cancer. 2006; 42: 1848–1857.
  19. Magaji B A, Moy F M, Roslani AC, Law CW, Sagap I. Psychometric Validation of the Malaysian Chinese Version of the EORTC QLQC30 in Colorectal Cancer Patients; Asian Pacific Journal of Cancer Prevention. 2015; 16: 8107-8112.
  20. Pachler J, Wille-Jorgensen P. (Quality of life after rectal resection for cancer. with or without permanent colostomy. Cochrane Database Syst Rev. 2012; 12: 4323.
  21. Mrabti H, Amziren M, ElGhissassi I, Bensouda Y, Berrada N, et al. Quality of life of early stage colorectal cancer patients in Morocco. BMC Gastroenterology. 2016; 16: 131.
  22. Kuzu MA, Topcu O, Ucar K, Ulukent S, Unal E, et al. Effect of sphincter-sacrificing surgery for rectal carcinoma on quality of life in Muslim patients. Dis Colon Rectum. 2002; 45: 1359–1366.
  23. Souadka A, Majbar MA, El Harroudi T, Benkabbou A, Souadka A, et al. Amine Perineal pseudocontinent colostomy is safe and efficient technique for perineal reconstruction after abdominoperineal resection for rectal adenocarcinoma. BMC Surg. 2015; 15: 40.
  24. Cakmak A, Aylaz G, Kuzu MA. Permanent stoma not only affects patients’ quality of life but also that of their spouses. World J Surg. 2010; 34: 2872–2876.
  25. Peng J, Shi D, Goodman KA, Goldstein D, Xiao C, et al. Early results of quality of life for curatively treated rectal cancers in Chinese patients with EORTC QLQ-CR29 Pengetal. Radiation Oncology. 2011; 6: 93.